Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: J Consult Clin Psychol. 2013 Feb 4;81(3):518–527. doi: 10.1037/a0031730

Table 2.

BDI-II data for all participants who completed the BDI-II in each study.

Study Group N BDI-II
Range		 BDI-II Mean
(SD)
Study 1a 108 16–50 24.41 (8.00)
Study 1b 40 16–56 25.42 (9.36)
Study 2
(BDI-II
High-scorers)		 Malleable
Condition		 81 16–59 26.27 (9.70)
Control
Condition		 65 16–46 24.69 (7.80)
Bio. Illness
Condition		 86 16–54 25.24 (8.96)
Study 2
(BDI-II
Low-scorers)		 Malleable
Condition		 127 0–15 7.06 (4.35)
Control
Condition		 131 0–15 6.65 (4.50)
Bio. Illness
Condition		 127 0– 15 6.95 (4.56)